Aroa Biosurgery Investor Relations Material
Latest events
Q2 2025
Aroa Biosurgery
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies
Latest reports from Aroa Biosurgery Limited
Access all reports
Aroa Biosurgery Limited , a regenerative medicine company, engages in the developing, manufacturing, and selling of medical devices for wound and tissue repair using extracellular matrix (ECM) technology in the United States and internationally. The company offers an injectable dermal substitute, dermadoctor; surgical implants and kits, such as Aroabifix Stapleless, AroaBifix Ultra Nail, AroaBifix2 Inlay, AroaBifix2 Thin Mesh, AroaBifix2 Thin Mesh 2-pack; and a wide range of medical supplies for surgical applications in North America. It also provides water soluble reconstructive meshes for use as surgical implant. The company markets its products through direct sales to hospitals, distributors and surgeons through its field sales offices located in 10 cities throughout the United States.
Key slides for Aroa Biosurgery Limited
Q2 2025
Aroa Biosurgery Limited
Q2 2025
Aroa Biosurgery Limited
Latest articles
Deere & Company: Shaping the Future of Agriculture Since 1837
Detailing the history of agriculture and Deere & Company, all the way from 1837 to the present day.
25 Oct 2024
Intel: Semiconductors & Strategic Inflection Points
Founded in 1968, Intel has been a key player in the American semiconductor industry, with its processors powering computers worldwide.
15 Oct 2024
Our Favorite Spin-off Stories Since 2000
Spin-off motives vary widely across different companies, but the underlying objective remains the same: enhancing long-term shareholder value.
17 Oct 2024
Ticker symbol
ARX
Country
🇦🇺 Australia